Histone deacetylase inhibitor trichostatin A synergistically resensitizes a gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor and AKT activation
Author(s) -
BiWen Yeh,
WeiMing Li,
ChingChia Li,
Wan-Yi Kang,
ChunNung Huang,
TzyhChyuan Hour,
ZiMiao Liu,
HueiSheng Huang,
WenJeng Wu
Publication year - 2015
Publication title -
urological science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 8
eISSN - 1879-5234
pISSN - 1879-5226
DOI - 10.1016/j.urols.2015.06.204
Subject(s) - trichostatin a , medicine , histone deacetylase inhibitor , cancer research , gemcitabine , histone deacetylase , protein kinase b , urothelial carcinoma , histone , cancer , bladder cancer , signal transduction , microbiology and biotechnology , biology , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom